Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Luminate Medical, a Galway-headquartered medtech company, has raised $15 million in a Series A funding round to support its innovative cancer care solutions. The funding will help bring their hair-saving chemo helmet, Lily, closer to release. This helmet aims to prevent hair loss, a common side effect of chemotherapy, thereby improving the quality of life for cancer patients. The new funding will also be directed toward expanding at-home cancer care services, making treatment more accessible and comfortable for patients. Aaron Hannon, a key figure in the company, was mentioned in the announcement by TechCrunch.
Helmet that prevents chemo patients from going bald?! Amazing. https://t.co/BpftZyXrEK https://t.co/I5mhivFnIx
Congrats to the team @LuminateMed (YC S21) on the $15M Series A! Luminate makes devices that help cancer patients prevent the side effects of cancer treatment. Their first product, Lily, is a cap that enables chemotherapy patients to prevent hair loss. https://t.co/hYRWRIZaT6
Galway-headquartered medtech Luminate Medical has raised $15m to bring its cancer care to more patients in the comfort of their own homes. https://t.co/2PHoTVqV8f